Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
JournalBasic and Clinical Pharmacology and Toxicology
DOIs
Publication statusPublished - Mar 2021

Cite this